SEC Form 4 · accession 0000939767-16-000292
EXELIXIS, INC. · EXEL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Carl B Feldbaum
Director
Period of report
Dec 16, 2016
Accepted (ET)
Dec 16, 2016 · 7:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000939767
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 16, 2016 | M | 25,000 | $10.41 | A | 73,721 | D | |
| Common StockF2 | Dec 16, 2016 | S | 25,000 | $17.03 | D | 48,721 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F3 | $10.41 | Dec 16, 2016 | M | 25,000 | D | Feb 8, 2007 | Feb 7, 2017 | Common Stock | 25,000 | 0 | D |
Explanation of responses
- F1Includes 2,172 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- F2Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.02 to $17.08. Reporting person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
- F3The option, representing the right to purchase a total of 25,000 shares of Exelixis, Inc. common stock, was exercisable immediately upon grant and became fully vested on February 8, 2011.